Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: Clinical and cost-utility analyses

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 5, 2009, Pages 473-482

  Quigley, Martin M ^a   Mate, Timothy P ^b   Sylvester, John E ^b,c  

^a Calypso Medical Technologies   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c Seattle Prostate Institute   (United States)

Author keywords

Electromagnetic; Localization; Monitoring; Prostate; Radiation therapy; Radiofrequency

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COST UTILITY ANALYSIS; DEVICE; ELECTROMAGNETIC PATIENT POSITIONING SYSTEM; HUMAN; IMAGING SYSTEM; MALE; MEASUREMENT; PATIENT POSITIONING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE TUMOR; QUALITY OF LIFE; TRANSPONDER; TREATMENT OUTCOME; X RAY;

AGED; COST-BENEFIT ANALYSIS; ELECTROMAGNETIC PHENOMENA; HUMANS; MALE; MIDDLE AGED; MOVEMENT; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; QUALITY-ADJUSTED LIFE YEARS; RADIATION ONCOLOGY; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 69249097924     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.04.017     Document Type: Article

References (15)

1. American Cancer Society. Cancer Facts and Figures 2006. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf Accessed January 20, 2008
2. Foroudi F., Tyldesley S., Barbera L., et al. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys 55 (2003) 51-63
3. NOMOS Radiation Oncology. Image Guided Radiation Therapy. http://www.nasmedical.com/binary?id=2764 Accessed January 20, 2008
4. BrainLAB AG. IGRT ExacTrac Brochure. http://www.brainlab.com/download/pdf/IGTExacTracBrochure.pdf Accessed January 20, 2008
5. Konski A., Watkins-Bruner D., and Feigenberg S. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 408-415
6. Berger A.P., Gozzi C., Steiner H., et al. Complication rate of transrectal ultrasound guided prostate biopsy: A comparison among three protocols with 6, 10, and 15 cores. J Urol 171 (2004) 1478-1480
7. Henry A.M., Wilkinson C., Wylie J.P., et al. Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: An assessment of procedure related morbidity, patient acceptability, and accuracy. Radiother Oncol 73 (2004) 57-59
8. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549-1557
9. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1088-1098
10. Purdy J.A. Current ICRU definitions of volumes: Limitations and future directions. Semin Radiat Oncol 14 (2004) 27-40
11. Pickett B., Roach III M., Verhey L., et al. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. Intl J Radiat Oncol Biol Phys 32 (1995) 211-218
12. Roach III M., Pickett B., Rosenthal S.A., et al. Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys 28 (1994) 267-275
13. Schaly B., Bauman G.S., Song W., et al. Dosimetric impact of image-guided 3D conformal radiation therapy of prostate cancer. Phys Med Biol 50 (2005) 3083-3101
14. Beard C.J., Lamb C., Buswell L., et al. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiation Oncol Biol 41 (1998) 257-262
15. Roach M. Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer. Urol Clin N Am 31 (2004) 353-366